Axitinib
ATC L01EK01 · 11 markets · 67 records
GB 20 records · 4 strengths
CN 9 records · 2 strengths
ES 9 records · 3 strengths
- 5 mgtabletAXITINIB ACCORDAXITINIB STADA、AXITINIB TEVA、INLYTA
- 1 mgtabletAXITINIB ACCORDAXITINIB STADA、AXITINIB TEVA、INLYTA
- 3 mgtabletAXITINIB ACCORD
AU 7 records · 3 strengths
- 5 mgtabletINLYTAINLYTA axitinib 1 mg tablet blister pack、INLYTA axitinib 1 mg tablet bottle
- 1 mgtabletINLYTAINLYTA axitinib 1 mg tablet blister pack、INLYTA axitinib 1 mg tablet bottle
Records without a stated strength · 1 INLYTA
US 4 records · 2 strengths
SG 4 records · 2 strengths
- 5 mgtabletAXITINIB SANDOZ FILM COATED TABLET 5 MGINLYTA
- 1 mgtabletAXITINIB SANDOZ FILM COATED TABLET 5 MGINLYTA
MX 3 records · 1 strengths
- 5 mgtabletANIBYCAXETIB、LENKLYRA
CA 2 records · 2 strengths
TW 2 records · 2 strengths
HK 2 records · 1 strengths
Records without a stated strength · 1 INLYTA
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 AXITINIB ACCORD、INLYTA
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 mg tablet | INLYTA | No trade name INLYTA | INLYTA | INLYTA INLYTA axitinib 1 mg tablet blister pack INLYTA axitinib 1 mg tablet bottle | AXITINIB SANDOZ FILM COATED TABLET 5 MG INLYTA | Manufacturer: 山东新时代药业有限公司 ×5 英立达阿昔替尼 | AXITINIB ACCORD AXITINIB STADA AXITINIB TEVA+1INLYTA | ANIBY CAXETIB LENKLYRA | INLYTA 抑癌特膜衣錠 5 毫克 | ||
| 1 mg tablet | INLYTA | No trade name INLYTA | INLYTA | INLYTA INLYTA axitinib 1 mg tablet blister pack INLYTA axitinib 1 mg tablet bottle | AXITINIB SANDOZ FILM COATED TABLET 5 MG INLYTA | 英立达阿昔替尼 | AXITINIB ACCORD AXITINIB STADA AXITINIB TEVA+1INLYTA | INLYTA 抑癌特膜衣錠 1 毫克 | |||
| 3 mg tablet | No trade name INLYTA | AXITINIB ACCORD | |||||||||
| 7 mg tablet | No trade name INLYTA | ||||||||||
unknown | INLYTA | INLYTA | AXITINIB ACCORD INLYTA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in AU · HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en AU · HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 AU · HK · EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 AU · HK · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.